 |
|
Short-term Efficacy of Intravitreal Bavacizumab for Polypoidal Choroidal Vasculopathy.
Min Ho Lee, Jin Hwan An, Ji Eun Lee, Boo Sub Oum
J Korean Ophthalmol Soc. 2009;50(1):51-60. Published online 2009 Jan 15 DOI: https://doi.org/10.3341/jkos.2009.50.1.51
|
|
Citations to this article as recorded by
 Long-term Recurrence in Neovascular Age-related Macular Degeneration or Polypoidal Choroidal Vasculopathy without First Year Recurrence
Kee Sun Tae, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2018; 59(10): 908. CrossRef Long-term Treatment Outcome of Intravitreal Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
Ye Ji Kim, Sang Yun Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2018; 59(3): 238. CrossRef A Case of Subretinal Hematoma Secondary to Polypoidal Choroidal Vasculopathy Misunderstood as a Subretinal Mass
Jae Hoon Kim, Nam Ju Moon, Ho Kyun Cho
Journal of the Korean Ophthalmological Society.2010; 51(4): 616. CrossRef Electrophysiological and Morphological Changes After Intravitreal Bevacizumab Injection with Macular Edema or Choroidal Neovascularization
Hyun Joon Lee, Joo Youn Park, Young-Hoon Ohn
Journal of the Korean Ophthalmological Society.2009; 50(12): 1824. CrossRef
|